Friday, July 25, 2014

Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy …

Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced successful results from its randomized, double-blind, placebo-controlled phase II trial of VGX-3100 in women with biopsy-proven cervical intraepithelial neoplasia 2/3 (CIN2/3) associated with human papillomavirus (HPV) types 16 or 18. More …

Friday, July 25, 2014

Informed Consent: False Positives Not a Worry in Lung Cancer Study

The U.S. Preventive Services Task Force recently recommended computerized tomography (CT) lung screening for people at high risk for cancer, but a potential problem with CT is that many patients will have positive results on the screening test, only to be deemed cancer-free on further testing. More …